Antengene Corporation Limited（06996.HK）股價、圖表、新聞與AI分析

Q: Antengene Corporation Limited 的 CEO 是誰？

Dr. Jay Mei 是 Antengene Corporation Limited 的 Executive Chairman of the Board，自 2018 加入公司。

Q: ANTENGENE-B 股票的價格表現如何？

ANTENGENE-B 的當前價格為 $3.56，在上個交易日 下降 了 2.19%。

Q: Antengene Corporation Limited 的主要業務主題或行業是什麼？

Antengene Corporation Limited 屬於 Pharmaceuticals 行業，該板塊是 Health Care

Q: Antengene Corporation Limited 的市值是多少？

Antengene Corporation Limited 的當前市值是 $2.1B

首頁

股票

06996.HK

ANTENGENE-B (06996.HK)

Antengene Corporation Limited

HK$3.56

-2.19%

$-0.08

盤中： Jan 21, 14:04:29 HKT

關鍵數據

前收市價

$3.7

開盤價

$3.64

當日範圍

$3.54 - $3.68

52週區間

$0.69 - $8.16

交易量

1.7M

平均成交量

2.4M

每股盈餘 (TTM)

-0.40

股息收益率

市值

$2.1B

什麼是 ANTENGENE-B？

Antengene Corp. Ltd. operates as a clinical-stage Asia-Pacific biopharmaceutical company. The company is headquartered in Shanghai, Shanghai and currently employs 152 full-time employees. The company went IPO on 2020-11-20. The firm is principally engaged in the discovery, development, manufacturing and commercialization of biotech products. The firm's products include ATG-010 (selinexor), treating for relapsed/refractory multiple myeloma, relapsed/refractory diffuse large B-cell lymphoma and non-small cell lung cancer and ATG-008 (onatasertib), treating for hepatocellular carcinoma and non-small cell lung cancer. The firm mainly conducts its business in Asia-Pacific.

功能特性

交易策略